Blistering Dermatoses Flashcards
1st site of PV
Mouth (60%)> site of injury
MC ab in PV
Dgl 3
Mucocutaneous PV
Dgl 3 + 1
Predominate dgl 3 ab
Mucosal lesions predominate
PV pathophys
Plasminogen activator associated with ab mediated acantholysis
Th 2 ( but Th1 may be involved more in chronic
PV associations
Myesthenia gravis and thymoma
PV treatment
Steroids ā> cellcept > azathioprine
Some consider rituximab first line
Continue meds until ab disappear then repeat DIF to predict remission
Dominant autoimmune epitope in PV and PF
N-terminal extracellular domain of dsg 1
Fogo selvagem
IL-1beta increased, strong Th1, IgM anti dsg 1
% of pts with pemphigus erythematosus and pos lupus band
80%
Dsg 1, BP230, periplakin
Definitive test in PNP
Immunoprecipitation reveals immune response against Desmoplakin, envoplakin, BPAG1, periplakin
Also dsg 1 and 3 - dsg 3 ab epitope spread broadly through the extracellular domain (vs PV)
IgG1 and 2 predominant (vs 4 in PV)
HLA for PNP - significant
HLA-DRB1*03
Ag in localized vulvar BP in young girls
230 kd ag
% of BP with oral
20%
LP pemphigoides ag
230, 180 and unique 200 kd